Identification of heparin-binding EGF-like growth factor (HB-EGF) as a biomarker for lysophosphatidic acid receptor type 1 (LPA1) activation in human breast and prostate cancers.

by Marion David, Debashish Sahay, Florence Mege, Françoise Descotes, Raphaël Leblanc, Johnny Ribeiro, Philippe Clézardin, Olivier Peyruchaud
Published 2014-01-01

Diagnostic value and relative weight of sequence-specific magnetic resonance features in characterizing clinically significant prostate cancers.

by Olivier Rouvière, Tristan Dagonneau, Fanny Cros, Flavie Bratan, Laurent Roche, Florence Mège-Lechevallier, Alain Ruffion, Sébastien Crouzet, Marc Colombel, Muriel Rabilloud
Published 2017-01-01